EGFR and nonpapillary renal cell carcinoma: Elevated HIF consequent to VHL loss upregulates TGF-α, an EGFR ligand, in ccRCC tumors and cell lines while reintroduction of wild type pVHL attenuates TGF-α expression in ccRCC cells [78,79].